tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ocular Therapeutix: Buy Rating Affirmed Amid Promising Clinical Advancements and Strong Financial Position
PremiumRatingsOcular Therapeutix: Buy Rating Affirmed Amid Promising Clinical Advancements and Strong Financial Position
29d ago
Ocular Therapeutix price target raised to $29 from $20 at Citizens JMP
Premium
The Fly
Ocular Therapeutix price target raised to $29 from $20 at Citizens JMP
29d ago
Ocular Therapeutix’s Strategic Initiatives and Clinical Advancements Drive Buy Rating
Premium
Ratings
Ocular Therapeutix’s Strategic Initiatives and Clinical Advancements Drive Buy Rating
29d ago
Ocular Therapeutix initiated with a Buy at Chardan
PremiumThe FlyOcular Therapeutix initiated with a Buy at Chardan
1M ago
Promising Developments and Strategic Advancements Support Buy Rating for Ocular Therapeutix
Premium
Ratings
Promising Developments and Strategic Advancements Support Buy Rating for Ocular Therapeutix
3M ago
Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating
Premium
Ratings
Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating
3M ago
Ocular Therapeutix Earnings Call: Positive Outlook Amid Trial Progress
PremiumCompany AnnouncementsOcular Therapeutix Earnings Call: Positive Outlook Amid Trial Progress
3M ago
Ocular Therapeutix reports Q2 EPS (39c), consensus (35c)
Premium
The Fly
Ocular Therapeutix reports Q2 EPS (39c), consensus (35c)
3M ago
Ocular Therapeutix sees cash runway into 2028
Premium
The Fly
Ocular Therapeutix sees cash runway into 2028
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100